CN101358967B - 一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 - Google Patents
一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 Download PDFInfo
- Publication number
- CN101358967B CN101358967B CN200810118444XA CN200810118444A CN101358967B CN 101358967 B CN101358967 B CN 101358967B CN 200810118444X A CN200810118444X A CN 200810118444XA CN 200810118444 A CN200810118444 A CN 200810118444A CN 101358967 B CN101358967 B CN 101358967B
- Authority
- CN
- China
- Prior art keywords
- chlorpromazine
- liquid
- kit
- haptens
- antiantibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 title claims abstract description 119
- 229960001076 chlorpromazine Drugs 0.000 title claims abstract description 119
- 238000000034 method Methods 0.000 title claims abstract description 47
- 238000008157 ELISA kit Methods 0.000 title 1
- 239000007788 liquid Substances 0.000 claims abstract description 109
- 102000004190 Enzymes Human genes 0.000 claims abstract description 75
- 108090000790 Enzymes Proteins 0.000 claims abstract description 75
- 238000001514 detection method Methods 0.000 claims abstract description 20
- 239000000243 solution Substances 0.000 claims description 40
- 239000000427 antigen Substances 0.000 claims description 37
- 102000036639 antigens Human genes 0.000 claims description 37
- 108091007433 antigens Proteins 0.000 claims description 37
- 239000011248 coating agent Substances 0.000 claims description 35
- 238000000576 coating method Methods 0.000 claims description 35
- 238000002372 labelling Methods 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 33
- 239000000872 buffer Substances 0.000 claims description 29
- 241001494479 Pecora Species 0.000 claims description 25
- 102000014914 Carrier Proteins Human genes 0.000 claims description 24
- 108010078791 Carrier Proteins Proteins 0.000 claims description 24
- 239000012086 standard solution Substances 0.000 claims description 23
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 22
- 108010058846 Ovalbumin Proteins 0.000 claims description 22
- 229940092253 ovalbumin Drugs 0.000 claims description 22
- 210000002966 serum Anatomy 0.000 claims description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- 239000003814 drug Substances 0.000 claims description 20
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 18
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 18
- 239000007853 buffer solution Substances 0.000 claims description 18
- 239000000758 substrate Substances 0.000 claims description 17
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 16
- 210000004408 hybridoma Anatomy 0.000 claims description 14
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 14
- 229940033663 thimerosal Drugs 0.000 claims description 14
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 13
- ZGUGWUXLJSTTMA-UHFFFAOYSA-N Promazinum Chemical compound C1=CC=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZGUGWUXLJSTTMA-UHFFFAOYSA-N 0.000 claims description 13
- 239000000460 chlorine Substances 0.000 claims description 13
- 229910052801 chlorine Inorganic materials 0.000 claims description 13
- 238000004140 cleaning Methods 0.000 claims description 13
- 229960003598 promazine Drugs 0.000 claims description 13
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 12
- 230000008878 coupling Effects 0.000 claims description 12
- 238000010168 coupling process Methods 0.000 claims description 12
- 238000005859 coupling reaction Methods 0.000 claims description 12
- 239000003550 marker Substances 0.000 claims description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 9
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 claims description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 8
- 230000001900 immune effect Effects 0.000 claims description 8
- 230000028327 secretion Effects 0.000 claims description 8
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 7
- 229940098773 bovine serum albumin Drugs 0.000 claims description 7
- 239000008363 phosphate buffer Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 5
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 5
- 238000002203 pretreatment Methods 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- NFJCQBGAUBIGKV-UHFFFAOYSA-N nitro dihydrogen phosphate Chemical compound OP(O)(=O)O[N+]([O-])=O NFJCQBGAUBIGKV-UHFFFAOYSA-N 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 102000008946 Fibrinogen Human genes 0.000 claims description 2
- 108010049003 Fibrinogen Proteins 0.000 claims description 2
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 2
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 2
- 229940012952 fibrinogen Drugs 0.000 claims description 2
- 108060003552 hemocyanin Proteins 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 3
- 238000012544 monitoring process Methods 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract description 2
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 239000003547 immunosorbent Substances 0.000 abstract 3
- 239000000523 sample Substances 0.000 description 41
- 239000012530 fluid Substances 0.000 description 24
- 238000002360 preparation method Methods 0.000 description 23
- 238000002965 ELISA Methods 0.000 description 22
- 238000012360 testing method Methods 0.000 description 18
- 238000002835 absorbance Methods 0.000 description 10
- 241000287828 Gallus gallus Species 0.000 description 8
- 239000012488 sample solution Substances 0.000 description 8
- 238000013016 damping Methods 0.000 description 7
- 238000004321 preservation Methods 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 239000000376 reactant Substances 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000008676 import Effects 0.000 description 5
- 235000015277 pork Nutrition 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 4
- 241000238557 Decapoda Species 0.000 description 4
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000005847 immunogenicity Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 229960002319 barbital Drugs 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- OTNVGWMVOULBFZ-UHFFFAOYSA-N sodium;hydrochloride Chemical compound [Na].Cl OTNVGWMVOULBFZ-UHFFFAOYSA-N 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- JDXQWYKOKYUQDN-UHFFFAOYSA-N 3-hydroxypyrrolidine-2,5-dione Chemical compound OC1CC(=O)NC1=O JDXQWYKOKYUQDN-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical class OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100033195 DNA ligase 4 Human genes 0.000 description 1
- 235000016936 Dendrocalamus strictus Nutrition 0.000 description 1
- 101000927810 Homo sapiens DNA ligase 4 Proteins 0.000 description 1
- 244000118681 Iresine herbstii Species 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 1
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- NOSIYYJFMPDDSA-UHFFFAOYSA-N acepromazine Chemical compound C1=C(C(C)=O)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 NOSIYYJFMPDDSA-UHFFFAOYSA-N 0.000 description 1
- 229960005054 acepromazine Drugs 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- -1 amino amino Chemical group 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- XTKDAFGWCDAMPY-UHFFFAOYSA-N azaperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCN(C=2N=CC=CC=2)CC1 XTKDAFGWCDAMPY-UHFFFAOYSA-N 0.000 description 1
- 229950003616 azaperone Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000010813 municipal solid waste Substances 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 150000002990 phenothiazines Chemical class 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
药物名称 | 交叉反应率(%) |
氯丙嗪 | 100 |
异丙嗪 | 1 |
乙酰丙嗪 | <0.5 |
氟哌啶醇 | <0.1 |
阿扎哌隆 | <0.1 |
阿扎哌醇 | <0.5 |
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810118444XA CN101358967B (zh) | 2008-08-22 | 2008-08-22 | 一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810118444XA CN101358967B (zh) | 2008-08-22 | 2008-08-22 | 一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101358967A CN101358967A (zh) | 2009-02-04 |
CN101358967B true CN101358967B (zh) | 2012-07-25 |
Family
ID=40331471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200810118444XA Expired - Fee Related CN101358967B (zh) | 2008-08-22 | 2008-08-22 | 一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101358967B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102236012A (zh) * | 2010-04-21 | 2011-11-09 | 深圳出入境检验检疫局食品检验检疫技术中心 | 检测氯丙嗪的时间分辨荧光免疫分析试剂盒及其检测方法 |
CN101987836B (zh) * | 2010-08-31 | 2012-11-07 | 华南农业大学 | 氯丙嗪半抗原、人工抗原和抗体及其制备方法和应用 |
CN102368072B (zh) * | 2011-06-30 | 2014-09-24 | 同昕生物技术(北京)有限公司 | 检测环孢霉素a药物浓度的化学发光酶联免疫检测试剂盒 |
CN103616506B (zh) * | 2013-12-11 | 2015-04-15 | 山东博科生物产业有限公司 | 一种酶标抗体试剂 |
CN104530239B (zh) * | 2014-12-26 | 2017-12-05 | 华中农业大学 | 用于检测吩噻嗪类药物的单克隆抗体及酶联免疫方法与试剂盒 |
CN107607721B (zh) * | 2017-09-16 | 2020-08-28 | 北京勤邦生物技术有限公司 | 一种氯丙嗪的磁免疫化学发光检测试剂盒及其应用 |
CN114410637B (zh) * | 2022-01-24 | 2023-07-25 | 江南大学 | 一种特异性结合氯丙嗪的核酸适配体的筛选及应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3976763A (en) * | 1975-04-30 | 1976-08-24 | Hoffmann-La Roche Inc. | Chlorpromazine assay |
EP0411945B1 (en) * | 1989-08-04 | 1996-10-30 | BEHRINGWERKE Aktiengesellschaft | Heterogeneous immunoassays |
CN101236200A (zh) * | 2008-02-06 | 2008-08-06 | 中国计量学院 | 氯丙嗪的酶联免疫试剂盒及其检测方法 |
-
2008
- 2008-08-22 CN CN200810118444XA patent/CN101358967B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3976763A (en) * | 1975-04-30 | 1976-08-24 | Hoffmann-La Roche Inc. | Chlorpromazine assay |
EP0411945B1 (en) * | 1989-08-04 | 1996-10-30 | BEHRINGWERKE Aktiengesellschaft | Heterogeneous immunoassays |
CN101236200A (zh) * | 2008-02-06 | 2008-08-06 | 中国计量学院 | 氯丙嗪的酶联免疫试剂盒及其检测方法 |
Non-Patent Citations (3)
Title |
---|
J.W.HUBBARD et al.Radioimmunoassay for Psychotropic Drugs I:Synthesis and Properties of Haptens for Chlorpromazine.《Journal of Pharmaceutical Sciences》.1978,第67卷(第11期), * |
John Cooper et al.Development of a rapid screening test for veterinary sedatives and the beta-blocker carazolol in porcine kidney by ELISA.《Analyst》.2004,第129卷(第2期), * |
龚福春等.4-羟基苯乙烯基吡啶为辣根过氧化物酶底物的酶荧光免疫传感体系测定布氏杆菌抗体.《化学学报》.2008,第66卷(第1期), * |
Also Published As
Publication number | Publication date |
---|---|
CN101358967A (zh) | 2009-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101256188B (zh) | 检测林可霉素药物的酶联免疫试剂盒及其应用 | |
CN101013129B (zh) | 检测呋喃西林代谢物的酶联免疫试剂盒及其应用 | |
CN101358967B (zh) | 一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 | |
CN101413943B (zh) | 一种检测三聚氰胺的方法及其专用酶联免疫试剂盒 | |
CN101571541B (zh) | 检测磺胺类药物的酶联免疫试剂盒及其方法 | |
CN101571539B (zh) | 检测头孢类药物的酶联免疫试剂盒及其应用 | |
CN101839918B (zh) | 一种检测螺旋霉素的方法及其专用酶联免疫试剂盒 | |
CN101021536B (zh) | 检测新霉素药物的酶联免疫试剂盒及方法 | |
CN102080066B (zh) | 一种检测t-2毒素的方法及其专用试剂盒 | |
CN101776685B (zh) | 检测三甲氧苄胺嘧啶药物的酶联免疫试剂盒及其应用 | |
CN101013130A (zh) | 检测呋喃它酮代谢物的酶联免疫试剂盒及其应用 | |
CN101571540B (zh) | 检测猪免疫球蛋白g的酶联免疫试剂盒及其应用 | |
CN1811436B (zh) | 一种检测恩诺沙星的方法及其专用酶联免疫试剂盒 | |
CN101358966B (zh) | 一种检测粘杆菌素的方法及其专用酶联免疫试剂盒 | |
CN101021535B (zh) | 检测庆大霉素药物的酶联免疫试剂盒及方法 | |
CN102967709A (zh) | 检测玉米赤霉烯酮药物的酶联免疫试剂盒及其应用 | |
CN101013131B (zh) | 呋喃妥因代谢物酶联免疫分析试剂盒及其应用 | |
CN101299045B (zh) | 检测氟苯尼考及氟苯尼考胺的方法及其专用酶联免疫试剂盒 | |
CN101349693A (zh) | 一种氟苯尼考类药物快速检测试剂盒及其应用 | |
CN101299046B (zh) | 一种检测红霉素类化合物的方法及其专用酶联免疫试剂盒 | |
CN101526528A (zh) | 呋喃它酮代谢物检测试剂盒 | |
CN101782579B (zh) | 检测泰妙菌素药物的酶联免疫试剂盒及其应用 | |
CN103018451A (zh) | 检测氯霉素的酶联免疫试剂盒及其应用 | |
CN101315377B (zh) | 一种检测莫能菌素的方法及其专用酶联免疫试剂盒 | |
CN100492009C (zh) | 检测氟甲喹药物的酶联免疫试剂盒及方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: BEIJING WANGER BIOTECHNOLOGY CO., LTD. Effective date: 20120605 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20120605 Address after: 102206 Beijing city Changping Huilongguan international information industry base, four High Street No. 8 Applicant after: Beijing Wanger Biotechnology Co.,Ltd. Address before: 102206 Beijing city Changping Huilongguan international information industry base, four High Street No. 8 Applicant before: Beijing Wanger Kangtai Biotechnology Co.,Ltd. Co-applicant before: Beijing Wanger Biotechnology Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120725 Termination date: 20210822 |